Forbes May 22, 2024
An FDA-approved AI algorithm was more likely to wrongly indicate the presence of cancer in Black women compared to White, Hispanic and Asian women, according to a new study.
“As more AI algorithms are becoming FDA approved for screening mammography, we were interested in knowing this performance was similar across all patient demographics and characteristics,” said Derek L. Nguyen, M.D., assistant professor at Duke University in Durham, North Carolina and lead author of the study. “The impact of patient characteristics on AI performance has not been well studied.”
The AI tool is FDA approved to help radiologists identify potentially concerning results on mammograms, which then leads to the patient being sent for further testing. There is some evidence that AI...
Today's Sponsors
Today's Sponsor